1. Get more info on this report!
Drug Delivery Markets: Oral Delivery
July 1, 2009
Since our last edition of this report in 2007, the oral drug delivery market is the largest
segment of the drug delivery market, and there’s no sign that it is slowing down. With
pharmaceutical companies increasingly turning to drug delivery to extend the revenue-
earning lifetime of their biggest products, and seeking to tap into the growing elderly
population that requires products with a level of ease-of-use and cost benefit, it’s no
surprise that the oral drug delivery market is a $35 billion industry and expected to grow
as much as ten percent per year.
Kalorama’s Drug Delivery Markets: Oral Delivery provides the definitive break down of
the market for oral delivery drug markets. The report covers both the major technologies
in oral delivery (controlled-release, delayed release, pulsatile-release, taste-masked and
microemulsion formulations) and the products that use these delivery technologies.
In the reporting of market size and growth through 2013, Kalorama’s unique analysis
breaks out separates the value of the technology portion of the market from the
active ingriedient portion of the market, allowing for a deeper understanding of the value
of the market attributable to the delivery technologies themselves.
This focused report provides information on the revenues for relevant companies and
provides information critical to assessing the opportunities available in this market,
including:
Legacy Companies in Oral Delivery as well as Recent Entrants
Current World Wide Revenue Across Product Categories and Future Forecasts
Revenues by Combonent and by Component ( Pharmaceutical vs. Technology
portion of Revenue) Type of Delivery (Timed Release vs. Other)
Challenges Faced by Oral-Delivery Technology Companies
Success Stories and Pitfalls
The Trends That are Expected to Lead to Global Growth
Kalorama’s trusted information-gathering process provides most accurate study of the
oral delivery drug market available today. Information and analysis presented in this
report is based on extensive interviews with senior management of top companies in

2. the industry. While major research literature and government information is culled,
information is corroborated and key market insights originate from interviews with
industry leaders.
Product managers, marketing managers, business development executives, advertising
agency or investment firm executives, and information and research center librarians
are among the individuals who will find this report on the oral delivery drug market
essential.
Additional Information
New York, July 14, 2009 — The worldwide market for oral drugs using drug delivery
technologies has experienced tremendous growth over the last few years according to
Drug Delivery Markets: Oral Delivery, a new report from Kalorama Information, a
leading publisher in the life sciences research market, a trajectory that is projected to
gain momentum through 2013 as other pharmaceutical product areas are challenged.
In 2008, the oral drug delivery market reached revenues at the manufacturer’s level of
$43 billion for both major technologies in oral delivery and the products that use these
delivery technologies. Kalorama forecasts the market will reach $71 billion by 2013, with
a compound annual growth rate (CAGR) of almost 11% for the five-year period
beginning in 2009.
Over the next few years, Kalorama projects consolidation will increasingly impact the
market as funding from big companies leads to better products and more research and
development. Large pharmaceutical companies are expected to continue acquiring drug
delivery companies to expand their presence, deepen product lines, and create
potential extensions for existing products; while larger drug delivery companies will
continue to acquire smaller start-up companies to broaden their drug delivery platforms.
“Those products with enhanced delivery technologies have a better chance of meeting
economic and patent challenges near-term,” says Bruce Carlson, publisher of Kalorama
Information. “That’s why we will see drug delivery companies become more involved
earlier in the research and development process. Higher-quality products with
exceptional drug delivery methods will encourage patient compliance and innovative
discoveries.”
Additional market drivers include growth in the elderly population, patent issues among
large pharmaceutical companies, differentiation of existing and future products by drug
delivery mechanism, population growth, and new developments in drug delivery that are
both fueling growth in the pharmaceutical market and providing opportunities to extend
product lifecycles.

3. Drug Delivery Markets: Oral Delivery provides the definitive breakdown of the global
oral drug delivery market. The report covers both the major technologies in oral delivery
(controlled-release, delayed release, pulsatile-release, taste-masked and microemulsion
formulations) and the products that use these delivery technologies. Included are
market size and growth through 2013, in addition to information critical to assessing the
opportunities available in the market.
About Kalorama Information
Kalorama Information supplies the latest in independent market research in the life
sciences, as well as a full range of custom research services.
TABLE OF CONTENTS
Chapter One: Executive Summary
Market Drivers
Market Size and Growth
o Total Oral Drug Delivery Market
o Oral Drug Delivery Technology Only Market
Competitive and Market Analysis
Chapter Two: Introduction and Overview
Scope of the Report
Methodology
History of Oral Drug Delivery
Phases of Drug Action
Barriers to Oral Drug Delivery
Controlled-Release/Sustained-Release
Delayed Release and Modified Release
Fast Dissolving
Taste-Masked
Pulsatile Release
Microemulsion and Others
Chapter Three: Key Trends and Demographics
The Elderly
Regulatory Environment
Patent Protection and Extension
Earlier Involvement

4. Consolidation
Proprietary Product Development
Implications for Generic and Over-the-Counter Products
Pharmaceutical Formulation
Chapter Four: New Developments
Macromolecule Delivery
Delivery of Hydrophobic Drugs
Other Delivery Solutions
Chapter Five: Market Size and Growth
The Total Oral Drug Delivery Market
Oral Delivery Technology Only Market
Chapter Six: Competitive Analysis
Competitive Landscape
Chapter Seven: Company Profiles
ALZA Corporation
Biovail Corporation
Elan Corporation, plc
Emisphere Technologies, Inc.
Ethypharm
KV Pharmaceutical
Labopharm, Inc.
Penwest Pharmaceutical Company
Purdue/MundiPharma/Napp Group
SkyePharma PLC
Watson Pharmaceuticals, Inc.
Chapte Eight: Companies in Brief
Alkermes, Inc.
Astellas Pharma US
CIMA Labs, Inc. Division of Cephalon
DepoMed, Inc.
Eurand, Inc.
Galenix
Intelgenx Technologies Corp
Kos Pharmaceuticals, Inc.
Lifecycle Pharma
MicroDose Therapeutics, Inc.
Scolr Pharma

5. Xcelience
Appendix: Company Directory
List of Exhibits
Chapter One: Executive Summary
Chapter Two: Introduction and Overview
Table 2-1: Selected Types of Oral Solid Preparations
Table 2-2: Sequence of Drug Action
Chapter Three: Key Trends and Demographics
Table 3-1: World Population by Age Group 2006-2013
Figure 3-1: World Population by Age Group 2006-2013
Table 3-2: Recent Consolidations in the Drug Delivery Market
Chapter Four: New Developments
Chapter Five: Market Size and Growth
Table 5-1: The Worldwide Market for Oral Drug Delivery Technology and
Pharmaceuticals Revenues and Growth Rate 2006-2013
Figure 5-1: Trending in the Worldwide Market for Oral Drug Delivery Technology
and Pharmaceuticals 2006-2013
Table 5-2: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug
Delivery Technologies by Type (Timed Release, Other) 2006-2013
Figure 5-2: Trending in the Worldwide Market for Pharmaceuticals Utilizing Oral
Drug Delivery Technologies by Type (Timed Release, Other) 2006-2013
Table 5-3: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Market
Share by Type 2006-2013
Table 5-4: The Worldwide Market for Oral Drug Delivery Systems by
Pharmaceutical vs Drug Delivery Components 2006-2013
Table 5-5: The Worldwide Market for Oral Drug Delivery Systems Distribution of
Revenue by Pharmaceutical vs Delivery Technology Components 2006-2013
Figure 5-3: The Worldwide Market for Oral Drug Delivery Systems Share of
Revenue by Pharmaceutical vs. Delivery Technology Component 2006, 2010
Chapter Six: Competitive Analysis
Table 6-1: Leading Suppliers of Oral Drug Delivery Technology (Company,
Proprietary Technology, Approved Products)

6. Available immediately for Online Download at
http://www.marketresearch.com/product/display.asp?productid=2290102
US: 800.298.5699
UK +44.207.256.3920
Int'l: +1.240.747.3093
Fax: 240.747.3004